Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReckitt Regulatory News (RKT)

Share Price Information for Reckitt (RKT)

Share Price is delayed by 15 minutes
Get Live Data
4,574.00    34.00 (0.75%)
Bid:
4,573.00
Ask:
4,575.00
Spread: 2.00 (0.044%)
Market Cap: £29.09b
RKT Live PriceLast checked at - London Stock Exchange

Intraday Reckitt Share Chart

Board Committee Changes

19 Jun 2024 07:36

RNS Number : 0233T
Reckitt Benckiser Group PLC
19 June 2024
 

19 June 2024

RECKITT BENCKISER GROUP PLC

 

BOARD COMMITTEE CHANGES

 

Reckitt Benckiser Group plc (the "Company" or "Reckitt") today announces a change to the Corporate Responsibility, Sustainability, Ethics and Compliance Committee, along with changes to the members of its Board Committees with immediate effect.  

 

Change to Corporate Responsibility, Sustainability, Ethics and Compliance Committee ("CRSECC")

Following a review of the role and scope of the CRSECC, it has been agreed by the Board to align the Committee to our Principal Risks related to product regulation, product quality & safety and legal & compliance. This will allow the Committee to focus on these critical areas and the culture of compliance at the Company. ESG and sustainability will return to the remit of the Board. Given the change in scope, the Committee has been renamed the Compliance Committee.

 

Changes to the members of its Board Committees

Following the recent changes in Directors at the AGM and the previously announced appointment of Fiona Dawson CBE to the Board, Sir Jeremy Darroch, Chair of the Board, has taken the opportunity to review the members of the Board Committees and confirms the Committee Chairs and members as follows:

 

The Audit Committee will continue to be chaired by Andrew Bonfield and the members are Elane Stock, Margherita Della Valle, and Tamara Ingram.

 

The Nomination Committee will be chaired by Jeremy Darroch and the members are Andrew Bonfield and Margherita Della Valle.

 

As previously announced, the Remuneration Committee will be chaired by Mary Harris until May 2025 at which point Fiona Dawson will become Chair. The members are Jeremy Darroch and Fiona Dawson.

 

The Compliance Committee will be chaired by Mehmood Khan and the members are Kris Licht and Marybeth Hays.

 

 

The Company confirms that there is no further information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to Fiona Dawson's appointment.

  

Contacts Details:

 

 

Catheryn O'Rourke +44 (0) 1753 217 800

General Counsel & Company Secretary

 

 

Richard Joyce +44 (0)7807 418516

Investor Relations

 

 

About Reckitt:

 

Reckitt* exists to protect, heal and nurture in the pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege.

 

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more.

 

Every day, around 30 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always.

 

We are a diverse global team of c. 40,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society. Find out more, or get in touch with us at www.reckitt.com

 

* Reckitt is the trading name of the Reckitt Benckiser group of companies

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSFDSMUELSEDM
Date   Source Headline
10th Jun 20267:00 amRNSTransaction in Own Shares
9th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20262:30 pmRNSEMTN Programme: Publication of Final Terms
8th Jun 20267:00 amRNSTransaction in Own Shares
5th Jun 20267:00 amRNSTransaction in Own Shares
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20261:26 pmRNSDirector/PDMR Shareholding
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20265:32 pmRNSDirector/PDMR Shareholding
1st Jun 20262:05 pmRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
26th May 20265:42 pmRNSEMTN Programme: Publication of Final Terms
26th May 20267:00 amRNSTransaction in Own Shares
22nd May 20267:00 amRNSTransaction in Own Shares
21st May 20264:44 pmRNSResult of AGM
21st May 20267:00 amRNSTransaction in Own Shares
20th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
18th May 20267:00 amRNSTransaction in Own Shares
15th May 202610:18 amRNSPublication of Supplementary Prospectus
15th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNS‘RECKITT FOCUS ON’ INVESTOR SEMINAR
14th May 20267:00 amRNSTransaction in Own Shares
13th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
11th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSTransaction in Own Shares
7th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20262:51 pmRNSTotal Voting Rights
1st May 20267:00 amRNSTransaction in Own Shares
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20263:30 pmRNSDirector/PDMR Shareholding
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20267:00 amRNSTransaction in Own Shares
23rd Apr 20263:00 pmRNSDirector Declaration
23rd Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSQ1 RESULTS 2026
22nd Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.